HEMATOLOGIC EFFECTS OF LOW-DOSE CONTINUOUS INFUSION INTERLEUKIN-2 WITH CONCOMITANT ALPHA-INTERFERON IN PATIENTS WITH METASTATIC SOLID MALIGNANCIES

被引：0
|
作者：
DAVE, HPG
WHITE, C
SCHULOF, R
AVIS, FP
机构：
[1] MT VERNON CANC INST,ALEXANDRIA,VA
[2] GEORGE WASHINGTON UNIV,MED CTR,DIV HEMATOL ONCOL,WASHINGTON,DC 20037
来源：
CLINICAL RESEARCH | 1991年 / 39卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A430 / A430
页数：1
相关论文
共 50 条
  • [1] SUBCUTANEOUS LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    RAVAUD, A
    NEGRIER, S
    CANY, L
    MERROUCHE, Y
    LEGUILLOU, M
    BLAY, JY
    CLAVEL, M
    GASTON, R
    OSKAM, R
    PHILIP, T
    BRITISH JOURNAL OF CANCER, 1994, 69 (06) : 1111 - 1114
  • [2] Response rates of patients with metastatic melanoma to high-dose intravenous interleukin-2 after prior exposure to alpha-interferon or low-dose interleukin-2
    Weinreich, DM
    Rosenberg, SA
    JOURNAL OF IMMUNOTHERAPY, 2002, 25 (02): : 185 - 187
  • [3] LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA
    WERSALL, JP
    MASUCCI, G
    HJELM, AL
    RAGNHAMMAR, P
    FAGERBERG, J
    FRODIN, JE
    MERK, K
    LINDEMALM, C
    ERICSON, K
    KALIN, B
    MELLSTEDT, H
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (03): : 103 - 111
  • [4] SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS ALPHA-INTERFERON IN ADVANCED MALIGNANT-MELANOMA
    DEBRAUD, F
    BIGANZOLI, L
    BAJETTA, E
    COLLEONI, M
    ZAMPINO, MG
    TUMORI, 1993, 79 (03) : 187 - 190
  • [5] IMMUNOLOGICAL MONITORING OF PATIENTS WITH ADVANCED KIDNEY CANCER TREATED WITH LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND INTERLEUKIN-2
    MASUCCI, G
    WERSALL, P
    MELLSTEDT, H
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 406 - 406
  • [6] Low-dose integrated chemoimmunohormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma - A pilot study
    Bernengo, MG
    Doveil, GC
    Bertero, M
    Quaglino, P
    Fierro, MT
    Savoia, P
    Appino, A
    Colonna, S
    MELANOMA RESEARCH, 1996, 6 (03) : 257 - 265
  • [7] Effects of low-dose recombinant interleukin-2 in human malignancies
    Lissoni, P
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 : S115 - S120
  • [8] SUBCUTANEOUS LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA (VOL 69, PG 1111, 1994)
    RAVAUD
    BRITISH JOURNAL OF CANCER, 1994, 70 (06) : 1284 - 1284
  • [9] THE IMPORTANCE OF ADDED ALBUMIN DURING CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-2 WITH ALPHA-INTERFERON
    CASSIDY, J
    POOLE, C
    SHARKIE, E
    STEWARD, WP
    KAYE, SB
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) : 1633 - 1634
  • [10] IMMUNOLOGICAL EFFECTS OF ALTERNATIVE WEEKLY INTERFERON-ALPHA-2B AND LOW-DOSE INTERLEUKIN-2 IN PATIENTS WITH CANCER
    FIORENTINO, B
    DISTEFANO, P
    GIULIANI, C
    AMATETTI, C
    TINARI, N
    NATOLI, C
    GARUFI, C
    IACOBELLI, S
    BRITISH JOURNAL OF CANCER, 1992, 66 (05) : 981 - 983
12345